Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bronchiectasis
100%
Cochrane Systematic Review
100%
Inhaled Corticosteroids
100%
Adverse Events
71%
Long-term Antibiotics
71%
Cochrane Review
71%
Mucolytics
57%
Hyperosmolar Agents
57%
Quality of Life
42%
Lung Function
42%
Airway Clearance Techniques
42%
Number of Participants
28%
Confidence Interval
28%
Wheezing
28%
Cough
28%
Dyspnea
28%
Antibiotics
28%
Small Clinical Trials
28%
Short Course
28%
RhDNase
28%
AMSTAR
28%
Physical Therapy
28%
Bromhexine
28%
Exacerbation Rate
28%
Improved Outcomes
14%
Clinical Practice
14%
Clinical Trials
14%
Odds Ratio
14%
Placebo
14%
Adverse Effects
14%
No Significant Difference
14%
Bronchi
14%
Treatment Effect
14%
Forced Expiratory Volume in 1 Second (FEV1)
14%
Non-cystic Fibrosis Bronchiectasis
14%
Clinically Significant
14%
Infective Exacerbation
14%
Oral Corticosteroids
14%
Clinical Practice Guidelines
14%
Chronic Cough
14%
Sputum Production
14%
Antibiotic Resistance
14%
Dilatation
14%
Quality of Life Improvement
14%
Adult Participants
14%
Grade Estimation
14%
Cochrane Database of Systematic Reviews
14%
Peto Odds Ratio
14%
Daily Activities
14%
Life Functioning
14%
Respiratory Failure
14%
Chest Pain
14%
Single Session
14%
Chronic Wet Cough
14%
Diarrhea
14%
Lung Function Impairment
14%
Erdosteine
14%
Nebulized Hypertonic Saline
14%
Rash
14%
Zero-P
14%
Summary of Findings
14%
DNase
14%
Recurrent Hospitalization
14%
Admission to Hospital
14%
Chronic Respiratory Diseases
14%
Lung Area
14%
Lack of Evidence
14%
Clinical Population
14%
Potential Harm
14%
Extracted Data
14%
Car-Free Day
14%
Evidence-based Support
14%
Benefit-harm
14%
High-priority Area
14%
Overall Coverage
14%
Evidence Map
14%
Medicine and Dentistry
Systematic Review
100%
Bronchiectasis
100%
Corticosteroid
100%
Antibiotics
87%
Adverse Event
62%
Coughing
50%
Quality of Life
50%
Lung
50%
Mucolytic Agent
50%
Lung Clearance
37%
Dyspnea
25%
Physiotherapy
25%
Wheeze
25%
Base
25%
Bromhexine
25%
Odds Ratio
25%
Thorax Pain
12%
Clinical Guideline
12%
Placebo
12%
Clinical Trial
12%
Cystic Fibrosis
12%
Antibiotic Resistance
12%
Sputum
12%
Chronic Respiratory Tract Disease
12%
Forced Expiratory Volume
12%
Respiratory Failure
12%
Erdosteine
12%
Clinical Population
12%
Diarrhea
12%
Exanthem
12%
Deoxyribonuclease
12%
Oral
12%
Table Salt
12%
Adverse Effect
12%